<it>KRAS </it>analysis in colorectal carcinoma: Analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice
<p>Abstract</p> <p>Background</p> <p>Epidermal growth factor receptor inhibitor therapy is now approved for treatment of metastatic colorectal carcinomas (CRC) in patients with tumors lacking <it>KRAS </it>mutations. Several procedures to detect <it>KRAS </it>mutations have been developed. However,...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2010-12-01
|
| Edice: | BMC Cancer |
| On-line přístup: | http://www.biomedcentral.com/1471-2407/10/660 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|